E. D. BATU AKAL Et Al. , "Serum autoantibodies and the risk of cancer in systemic sclerosis over time Reply," ARTHRITIS & RHEUMATOLOGY , no.12, pp.2267, 2023
BATU AKAL, E. D. Et Al. 2023. Serum autoantibodies and the risk of cancer in systemic sclerosis over time Reply. ARTHRITIS & RHEUMATOLOGY , no.12 , 2267.
BATU AKAL, E. D., ŞENER, S., & ÖZEN, S., (2023). Serum autoantibodies and the risk of cancer in systemic sclerosis over time Reply. ARTHRITIS & RHEUMATOLOGY , no.12, 2267.
BATU AKAL, EZGİ, SEHER ŞENER, And SEZA ÖZEN. "Serum autoantibodies and the risk of cancer in systemic sclerosis over time Reply," ARTHRITIS & RHEUMATOLOGY , no.12, 2267, 2023
BATU AKAL, EZGİ D. Et Al. "Serum autoantibodies and the risk of cancer in systemic sclerosis over time Reply." ARTHRITIS & RHEUMATOLOGY , no.12, pp.2267, 2023
BATU AKAL, E. D. ŞENER, S. And ÖZEN, S. (2023) . "Serum autoantibodies and the risk of cancer in systemic sclerosis over time Reply." ARTHRITIS & RHEUMATOLOGY , no.12, p.2267.
@article{article, author={EZGİ DENİZ BATU AKAL Et Al. }, title={Serum autoantibodies and the risk of cancer in systemic sclerosis over time Reply}, journal={ARTHRITIS & RHEUMATOLOGY}, year=2023, pages={2267} }